In the BioHarmony Drug Report Database

"Preview" Icon

Daptomycin

Cubicin, Cubicin Rf, Daptomycin (daptomycin) is a protein pharmaceutical. Daptomycin was first approved as Cubicin on 2003-09-12. It is used to treat bacteremia, bacterial infections, and bacterial skin diseases in the USA. It has been approved in Europe to treat bacteremia, bacterial endocarditis, bacterial skin diseases, gram-positive bacterial infections, and soft tissue infections. Cubicin’s patents are valid until 2033-09-11 (FDA).

 

Trade Name

 

Cubicin
 

Common Name

 

daptomycin
 

ChEMBL ID

 

CHEMBL387675
 

Indication

 

bacteremia, bacterial endocarditis, bacterial infections, bacterial skin diseases, gram-positive bacterial infections, soft tissue infections
 

Drug Class

 

Aptamers, classical and mirror; antibiotics (Streptomyces strains)

Image (chem structure or protein)

Daptomycin structure rendering